PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-78.03%
Negative revenue growth while 1177.HK stands at 3.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
110.95%
Gross profit growth above 1.5x 1177.HK's 2.64%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
No Data
No Data available this quarter, please select a different quarter.
-34.65%
Negative operating income growth while 1177.HK is at 16.58%. Joel Greenblatt would press for urgent turnaround measures.
-275.68%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-281.68%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-281.68%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.22%
Share change of 1.22% while 1177.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 1177.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.62%
OCF growth of 63.62% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
62.89%
FCF growth of 62.89% while 1177.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-99.87%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.90%
Negative 5Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
-144.81%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-118.30%
Negative 5Y OCF/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
-465.09%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-191.28%
Negative 5Y net income/share CAGR while 1177.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Cut dividends over 10 years while 1177.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.24%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.